Financial Highlights

Consolidated Income Statement

Figures in THBmn

  2014 2015 2016
Operating Revenue 7,730 7,945 8,810
Gross profit 3,105 3,406 3,678
Selling and Admin. Exp (SGA) 2,471 2,660 2,674
SGA (% to revenue) 32.0% 33.5% 30.4%
EBITDA 787 986 1,107
EBITDA (% to revenue) 10.2% 12.4% 12.6%
EBIT 655 841 955
Net Profit 548 696 795
Net profit (% to revenue) 7.1% 8.8% 9.0%
EPS (THB) 0.63 0.80 0.92
Return on equity 14.3% 16.7% 17.6%
Net cash from operations 614 609 1,260
Cash cycle (days) 121 129 121


Revenue by segments (THBmn)

  2014 2015 2016
Mega We CareTM Business 3,612 3,907 4,251
MaxxcareTM Business 3,694 3,558 4,160
OEM 424 480 399


Consolidated Balance Sheet

All figures in THBmn

  2014 2015 2016
Cash and bank balances1 1,281 1,467 1,217
Trade accounts receivable 2,024 2,263 2,233
Inventories 1,649 2,067 1,889
Property, plant and equipment 980 1,031 1,164
Intangible asset2 230 233 736
Other Assets 567 549 702
Total Assets 6,732 7,610 7,941
Debt 567 719 670
Trade Payables 1,306 1,603 1,519
Other Liabilityies 881 954 1,073
Total Outside Liabilities 2,754 3,275 3,261
Shareholder Equity 3,978 4,335 4,680
Total Liabilities and Equity 6,732 7,610 7,941


Key Balance Sheet elements

  2014 2015 2016
Net cash/(debt) (THBmn) 714 748 547
Capex spent3 (THBmn) 160 181 1,027
IBD/Equity (times) 0.14 0.17 0.14

1 Cash and Bank balances as at blances sheet dates include non-restricted term deposits with banks.
2 Intangible asstes as at Dec’16 includes THB 343mn relating to trademark and THB 154mn to goodwill arising from acquistion of Bio-Life Marketing Sdn.Bhd.
3 Capex spent means cash outflow on investment in property plant and equipments and business acqusitions. 2016 spending includes THB 592mn towards acqustion of Bio-Life Marketing Sdn.Bhd. (Malaysia).